Florida Drops Medicaid Coverage of Trans People’s Gender-Affirming Medications
The new rule preventing people from using Medicaid to pay for puberty blockers and hormone therapies will go into effect on Aug. 21.
Politics 
                            
Florida—under the leadership of the cartoonishly transphobic Gov. Ron DeSantis (R)—will bar its residents from using Medicaid to cover the puberty blockers and hormone therapies that many have already been using for yeas, according to a new rule released by the state’s Agency for Health Care Administration on Wednesday. This rule will not just affect trans kids, whose age-appropriate care the state has been trying to curb-stomp in one way or another—it will bar adults from continuing to use Medicaid to pay for gender-confirming medical care, too.
Under this guidance, the state’s $36.2 billion Medicaid program will not cover payment for treatments like hormone therapy or puberty blockers, nor for gender confirmation surgeries. This will add Florida to at least 10 states (including Texas and Arizona) which outlaw Medicaid dollars from being used for medications typically association with the treatment of gender dysphoria.
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
- 
        
        
            
 
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
        